CCR5 interactions with the variable 3 loop of gp120

被引:15
|
作者
Napier, Kelby B.
Wang, Zi-xuan
Peiper, Stephen C.
Trent, John O. [1 ]
机构
[1] Univ Louisville, Dept Med, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA
[3] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA
[4] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA
[5] Univ Louisville, Brown Canc Ctr, JG Brown Modeling Facil, Louisville, KY 40202 USA
关键词
HIV-1; CCR5; molecular modeling; gp120; V3; loop;
D O I
10.1007/s00894-006-0117-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The G-protein coupled receptor CCR5 functions pathologically as the primary co-receptor for macrophage tropic (R5) strains of HIV-1. The interactions responsible for co-receptor activity are unknown. Molecular-dynamics simulations of the extracellular and adjacent transmembrane domains of CCR5 were performed with explicit solvation utilizing a rhodopsin-based homology model. The functional unit of co-receptor binding was constructed via docking and molecular-dynamics simulation of CCR5 and the variable 3 loop of gp120, which is a dominant determinant of co-receptor utilization. The variable 3 loop was demonstrated to interact primarily with the amino terminus and the second extracellular loop of CCR5, providing novel structural information regarding the co-receptor-binding site. Alanine mutants that alter chemokine binding and co-receptor activity were examined. Molecular-dynamics simulations with and without the variable 3 loop of gp120 were able to rationalize the activities of these mutants successfully, providing support for the proposed model. Based on these results, the global complex of CCR5, gp120 including the V3 loop and CD4, was investigated. The utilization of computational analysis, in combination with molecular biological data, provides a powerful approach for understanding the use of CCR5 as a co-receptor by HIV-1.
引用
收藏
页码:29 / 41
页数:13
相关论文
共 50 条
  • [21] HIV gp120 interactions with coreceptors: Insights from studies with CCR5-based peptides
    Berger, Edward A.
    Alkhatib, Ghalib
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 403 - 407
  • [22] Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5
    Tam, Kayan
    Schultz, Megan
    Reyes-Robles, Tamara
    Vanwalscappel, Benedicte
    Horton, Joshua
    Alonzo, Francis, III
    Wu, Beili
    Landau, Nathaniel R.
    Torres, Victor J.
    [J]. MBIO, 2016, 7 (06):
  • [23] MODULATORY EFFECTS OF THE NOVEL CCR5 ANTAGONIST MARAVIROC ON MICROGLIAL PRO-INFLAMMATORY ACTIVATION ELICITED BY GP120
    Lisi, L.
    Navarra, P.
    Dello Russo, C.
    [J]. INFECTION, 2011, 39 : S35 - S35
  • [24] MONITORING THE INTERACTION BETWEEN THE HIV-1 GP120 V3 LOOP AND THE N-TERMINAL CCR5 PEPTIDE CONSTRUCTS THROUGH NMR SPECTROSCOPY
    Galanakis, P.
    Spyroulias, G. A.
    Morikis, D.
    Rizos, A.
    Krambovitis, E.
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 271 - 271
  • [25] NMR conformational studies of the interaction between the V3 loop of HIV-1 coat glycoprotein gp120 and chemokine receptor CCR5, at peptide level
    Galanakis, PA
    Kandias, N
    Spyroulias, GA
    Sioumpara, M
    Morikis, D
    Rizos, A
    Krambovitis, E
    [J]. FEBS JOURNAL, 2005, 272 : 548 - 548
  • [26] Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120
    Choe, H
    Li, WH
    Wright, PL
    Vasilieva, N
    Venturi, M
    Huang, CC
    Grundner, C
    Dorfman, T
    Zwick, MB
    Wang, LP
    Rosenberg, ES
    Kwong, PD
    Burton, DR
    Robinson, JE
    Sodroski, JG
    Farzan, M
    [J]. CELL, 2003, 114 (02) : 161 - 170
  • [27] Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
    David J Grainger
    Andrew ML Lever
    [J]. Retrovirology, 2
  • [28] Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
    Grainger, DJ
    Lever, AML
    [J]. RETROVIROLOGY, 2005, 2 (1)
  • [29] Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5
    Monde, Kazuaki
    Maeda, Yosuke
    Tanaka, Yuetsu
    Harada, Shinji
    Yusa, Keisuke
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (51) : 36923 - 36932
  • [30] gp120 Envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5
    Madani, N
    Kozak, SL
    Kavanaugh, MP
    Kabat, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8005 - 8010